HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The association of miR-29a with proteinuria in essential hypertension.

Abstract
Recently, miRNAs have emerged as new indirect markers of inflammation that are associated with adverse outcomes in cardiovascular disease. The aim of the study was to evaluate the relationship between miR29a and proteinuria in hypertension. Fifty patients with normal albuminuria, fifty patients with micro-albuminuria, and fifty patients with macro-albuminuria were enrolled. The highest levels of miR-29a and transforming growth factor-β1 (TGF-β1) were observed in the macro-albuminuria group, followed by the micro-albuminuria and the normal albuminuria groups. The level of miR-29a was negatively correlated with the glomerular filtration rate, but was positively correlated with C-reactive protein, TGF-β1, and the urinary albumin to creatinine ratio (UACR). Circulating miR-29a was found to be significantly and independently associated with proteinuria. Our findings showed that miR-29a reflects the pathogenesis of hypertensive nephropathy and may serve as a potential non-invasive marker for detecting early stages of hypertensive nephropathy.
AuthorsYu-Qing Huang, Cheng Huang, Jie Li, Bin Zhang, Ying-Qing Feng
JournalJournal of human hypertension (J Hum Hypertens) Vol. 32 Issue 11 Pg. 775-780 (11 2018) ISSN: 1476-5527 [Electronic] England
PMID30127486 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • MIRN29a microRNA, human
  • MicroRNAs
Topics
  • Aged
  • Cross-Sectional Studies
  • Essential Hypertension (urine)
  • Female
  • Humans
  • Male
  • MicroRNAs (blood)
  • Middle Aged
  • Proteinuria (blood)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: